Manfred Hinz from 3M new BVMed board member
02.10.2023 12:27
Manfred Hinz (53) from 3M Germany has been a new board member of the Federal Association of Medical Technology (BVMed) since October 1, 2023. He succeeds Ben Bake (52) from Sanitätshaus Aktuell, who will be leaving the company, on the nine-member BVMed board.
Manfred Hinz is Vice President Medical Solutions of the 3M Europe Middle East Africa (EMEA) Division. He is responsible for the medical technology business in Europe. 3M researches and produces at several locations in Germany. Hinz has 15 years of experience in medical and dental technology in national and international management roles as well as over 8 years of experience in the electronics, electrical and telecommunications industries.
He wants to work on the BVMed board to enable innovations and sustainability in medical technology, promote digitalization in the healthcare system and strengthen Germany as a production and development location: “For me, continuing to enable innovative and sustainable medical technology solutions in Germany is important Given the shortage of doctors and nursing staff, increasing pressure for efficiency and demographic change, this is absolutely necessary. To achieve this, innovation-promoting framework conditions must be designed with politics and self-administration, for example access to health data, effective approval and comprehensive benefit assessment,” says Hinz.
Ben Bake has been a BVMed board member since 2018 and contributed his experience as chairman of a nationwide service provider community of medical supply stores and homecare companies. The BVMed board would like to thank Ben Bake for his great commitment and active support in the further development of outpatient care structures.
The BVMed board consists of the chairman Dr. Meinrad Lugan (B. Braun), the deputy chairman of the board Dorothee Stamm (Medtronic) and Dr. Manfred W. Elff (Biotronik) as well as Kristof Boogaerts (Johnson & Johnson), Christian Hauer (Fresenius Kabi), Mark Jalaß (Lohmann & Rauscher), Marc D. Michel (Peter Brehm) and Ulrich Zihla (Paul Hartmann). The BVMed board is elected until April 2024. In addition, BVMed managing director Dr. Marc-Pierre Möll Member of the Board of Directors.